Stocks

Reddit Partners With OpenAI, RDDT Stock Pops 10%

Reddit (NYSE: RDDT) shares jumped 10% on Friday in response to its OpenAI partnership announcement. After yesterday’s closing bell, the…

Read More »

ELEVAI Labs Reports Q1 Earnings — Revenue Grows 330%

ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, reported its financial results for the first quarter ended March…

Read More »

GameStop Stock Soars Another 60% as Meme Stocks Reignite

For the second day in a row, GameStop (NYSE: GME) shares skyrocketed, extending Monday’s gains, which investors attributed to Roaring…

Read More »

Why Solar Energy Stocks Are Surging Today

It seems all the possibilities are on the table as some of the more volatile companies in energy see their…

Read More »

Reddit Stock Jumps 14% Following Strong Debut Earnings Report

Reddit (NYSE: RDDT) shares rallied 14% in after-hours trading today after the company released its quarterly earnings for the first…

Read More »

BofA Issues New Price Target on Reddit Stock Following $750 Million IPO

Reddit (NYSE: RDDT) went public in a much-anticipated initial public offering (IPO) on March 21, 2024. The social media company…

Read More »

Elon Musk Praises Novo Nordisk’s Weight-Loss Drug Ozempic as Solution to Childhood Obesity Epidemic

Tesla (NASDAQ: TSLA) and SpaceX CEO Elon Musk has sparked a conversation about childhood obesity and potential solutions after giving…

Read More »

Apple’s Q2 Earnings Beat Wall Street Forecast, Company Announces Huge Buyback

Apple (NASDAQ: AAPL) rose more than 7% in after-hours trading following the release of its Q2 earnings report. For the…

Read More »

ELEVAI Labs Announces Launch of ELEVAI Biosciences and ELEVAI Skincare Subsidiaries

ELEVAI Labs established two subsidiaries: ELEVAI Biosciences, Inc., and ELEVAI Skincare, Inc. ELEVAI Biosciences will focus on acquiring and developing…

Read More »

ELEVAI Labs Acquires Exclusive License to Develop and Commercialize Novel Assets to Treat Obesity and Muscle Loss Prevention

The agreement adds two drug candidates to the company’s product pipeline, “EL-22”, a clinical-stage engineered probiotic expressing myostatin, and “EL-32”,…

Read More »
Back to top button
🔔
Stay Updated!
Get notifications for new content